Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clones

  1. Anastasia A Minervina  Is a corresponding author
  2. Mikhail V Pogorelyy  Is a corresponding author
  3. Ekaterina A Komech
  4. Vadim K Karnaukhov
  5. Petra Bacher
  6. Elisa Rosati
  7. Andre Franke
  8. Dmitriy Chudakov
  9. Ilgar Z Mamedov
  10. Yuri B Lebedev
  11. Thierry Mora
  12. Aleksandra M Walczak
  1. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Federation
  2. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russia
  3. Skoltech, Russian Federation
  4. Kiel University, Germany
  5. École Normale Supérieure, France

Abstract

The diverse repertoire of T-cell receptors (TCR) plays a key role in the adaptive immune response to infections. Using TCR alpha and beta repertoire sequencing for T-cell subsets, as well as single-cell RNAseq and TCRseq, we track the concentrations and phenotypes of individual T-cell clones in response to primary and secondary yellow fever immunization — the model for acute infection in humans — showing their large diversity. We confirm the secondary response is an order of magnitude weaker, albeit ∼ 10 days faster than the primary one. Estimating the fraction of the T-cell response directed against the single immunodominant epitope, we identify the sequence features of TCRs that define the high precursor frequency of the two major TCR motifs specific for this particular epitope. We also show the consistency of clonal expansion dynamics between bulk alpha and beta repertoires, using a new methodology to reconstruct alpha-beta pairings from clonal trajectories.

Data availability

Sequencing data have been deposited in SRA under accession code PRJNA577794.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Anastasia A Minervina

    Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation
    For correspondence
    aminervina@mail.ru
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9884-6351
  2. Mikhail V Pogorelyy

    Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation
    For correspondence
    m.pogorely@gmail.com
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0773-1204
  3. Ekaterina A Komech

    Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
    Competing interests
    No competing interests declared.
  4. Vadim K Karnaukhov

    Center of Life Sciences, Skoltech, Moscow, Russian Federation
    Competing interests
    No competing interests declared.
  5. Petra Bacher

    Institute of Immunology, Kiel University, Kiel, Germany
    Competing interests
    No competing interests declared.
  6. Elisa Rosati

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2635-6422
  7. Andre Franke

    Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
    Competing interests
    No competing interests declared.
  8. Dmitriy Chudakov

    Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0430-790X
  9. Ilgar Z Mamedov

    Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation
    Competing interests
    No competing interests declared.
  10. Yuri B Lebedev

    Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4554-4733
  11. Thierry Mora

    Laboratoire de Physique, École Normale Supérieure, Paris, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5456-9361
  12. Aleksandra M Walczak

    Laboratoire de Physique Theorique, École Normale Supérieure, Paris, France
    Competing interests
    Aleksandra M Walczak, Senior editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2686-5702

Funding

European Research Council (Consolidator Grant no 724208)

  • Thierry Mora
  • Aleksandra M Walczak

Russian Science Foundation (15-15-00178)

  • Anastasia A Minervina
  • Mikhail V Pogorelyy
  • Ekaterina A Komech
  • Vadim K Karnaukhov
  • Yuri B Lebedev

Russian Foundation for Basic Research (18-29-09132)

  • Ilgar Z Mamedov

Russian Foundation for Basic Research (19-54-12011)

  • Ilgar Z Mamedov

Deutsche Forschungsgemeinschaft (Exc2167)

  • Petra Bacher
  • Elisa Rosati
  • Andre Franke

Deutsche Forschungsgemeinschaft (4096610003)

  • Elisa Rosati

Ministry of Science and Higher Education of the Russian Federation (075-15-2019-1660)

  • Dmitriy Chudakov

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: All donors gave written informed consent to participate in the study under the declaration of Helsinki. The blood was collected with informed consent in a certified diagnostics laboratory. The experimental protocol was approved by the Ethical Committee of the Pirogov Russian National Research Medical University, Russia (FLU0108, granted January 29, 2016).

Copyright

© 2020, Minervina et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,740
    views
  • 558
    downloads
  • 52
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Anastasia A Minervina
  2. Mikhail V Pogorelyy
  3. Ekaterina A Komech
  4. Vadim K Karnaukhov
  5. Petra Bacher
  6. Elisa Rosati
  7. Andre Franke
  8. Dmitriy Chudakov
  9. Ilgar Z Mamedov
  10. Yuri B Lebedev
  11. Thierry Mora
  12. Aleksandra M Walczak
(2020)
Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clones
eLife 9:e53704.
https://doi.org/10.7554/eLife.53704

Share this article

https://doi.org/10.7554/eLife.53704

Further reading

    1. Computational and Systems Biology
    2. Microbiology and Infectious Disease
    Gaetan De Waele, Gerben Menschaert, Willem Waegeman
    Research Article

    Timely and effective use of antimicrobial drugs can improve patient outcomes, as well as help safeguard against resistance development. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is currently routinely used in clinical diagnostics for rapid species identification. Mining additional data from said spectra in the form of antimicrobial resistance (AMR) profiles is, therefore, highly promising. Such AMR profiles could serve as a drop-in solution for drastically improving treatment efficiency, effectiveness, and costs. This study endeavors to develop the first machine learning models capable of predicting AMR profiles for the whole repertoire of species and drugs encountered in clinical microbiology. The resulting models can be interpreted as drug recommender systems for infectious diseases. We find that our dual-branch method delivers considerably higher performance compared to previous approaches. In addition, experiments show that the models can be efficiently fine-tuned to data from other clinical laboratories. MALDI-TOF-based AMR recommender systems can, hence, greatly extend the value of MALDI-TOF MS for clinical diagnostics. All code supporting this study is distributed on PyPI and is packaged at https://github.com/gdewael/maldi-nn.

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Sanjarbek Hudaiberdiev, Ivan Ovcharenko
    Research Article

    Enhancers and promoters are classically considered to be bound by a small set of transcription factors (TFs) in a sequence-specific manner. This assumption has come under increasing skepticism as the datasets of ChIP-seq assays of TFs have expanded. In particular, high-occupancy target (HOT) loci attract hundreds of TFs with often no detectable correlation between ChIP-seq peaks and DNA-binding motif presence. Here, we used a set of 1003 TF ChIP-seq datasets (HepG2, K562, H1) to analyze the patterns of ChIP-seq peak co-occurrence in combination with functional genomics datasets. We identified 43,891 HOT loci forming at the promoter (53%) and enhancer (47%) regions. HOT promoters regulate housekeeping genes, whereas HOT enhancers are involved in tissue-specific process regulation. HOT loci form the foundation of human super-enhancers and evolve under strong negative selection, with some of these loci being located in ultraconserved regions. Sequence-based classification analysis of HOT loci suggested that their formation is driven by the sequence features, and the density of mapped ChIP-seq peaks across TF-bound loci correlates with sequence features and the expression level of flanking genes. Based on the affinities to bind to promoters and enhancers we detected five distinct clusters of TFs that form the core of the HOT loci. We report an abundance of HOT loci in the human genome and a commitment of 51% of all TF ChIP-seq binding events to HOT locus formation thus challenging the classical model of enhancer activity and propose a model of HOT locus formation based on the existence of large transcriptional condensates.